Clinical Trials Logo

Phobia, Specific clinical trials

View clinical trials related to Phobia, Specific.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02789813 Completed - Phobia, Specific Clinical Trials

Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.

VALPRO
Start date: July 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether valproic acid in combination with fear memory reactivation is useful to enhance treatment stability of exposure therapy for specific phobia.

NCT ID: NCT02622087 Completed - Phobia, Specific Clinical Trials

The Impact of Sex Hormones on One-session Treatment for Spider Phobia in Women

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether levels of sex hormones (including estrogen and progesterone) influence women's response to treatment for Specific Phobia of spiders. It is hypothesised that women will show less relapse of symptoms of spider phobia if they receive treatment during a period of high levels of sex hormones.

NCT ID: NCT02533310 Completed - Phobia, Specific Clinical Trials

Virtual Reality Immersive Method for Spider (Phobia) Exposure Therapy (VIMSE)

VIMSE
Start date: August 1, 2015
Phase: N/A
Study type: Interventional

The aim of this study is to examine the efficacy of virtual reality exposure therapy as a treatment for specific phobia (spiders). A gamified virtual reality simulation of one-session therapy (VR-OST) will be compared to the gold-standard treatment in the form of traditional one-session phobia treatment (OST) using in-vivo stimuli. This study was powered to detect a non-inferiority margin of a 2-point difference between groups.